Inventor
LINNEY IAN
GB31 patents
⚠️ This page may combine multiple inventors who share the name “LINNEY IAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NIMBUS SATURN INC
10 patentsUS11034694B2Jun 15, 2021
Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
NIMBUS SATURN INC12 citations93
US11548890B1Jan 10, 2023
HPK1 antagonists and uses thereof
NIMBUS SATURN INC3 citations82
US11078201B2Aug 3, 2021
Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists
NIMBUS SATURN INC7 citations82
US11028085B2Jun 8, 2021
Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists
NIMBUS SATURN INC6 citations82
US11021481B2Jun 1, 2021
Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
NIMBUS SATURN INC7 citations82
US12466841B2Nov 11, 2025
Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
NIMBUS SATURN INC0 citations60
US12215105B2Feb 4, 2025
HPK1 antagonists and uses thereof
NIMBUS SATURN INC0 citations60
US12071442B2Aug 27, 2024
Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
NIMBUS SATURN INC0 citations60
US11926625B2Mar 12, 2024
HPK1 antagonists and uses thereof
NIMBUS SATURN INC1 citations56
US12252488B2Mar 18, 2025
HPK1 antagonists and uses thereof
NIMBUS SATURN INC0 citations46
CHIESI FARM SPA
8 patentsUS10004728B2Jun 26, 2018
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
CHIESI FARM SPA2 citations72
US9579314B2Feb 28, 2017
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
CHIESI FARM SPA2 citations72
US9662323B2May 30, 2017
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CHIESI FARM SPA2 citations62
US10117860B2Nov 6, 2018
Aminoester derivatives
CHIESI FARM SPA0 citations51
US9763924B2Sep 19, 2017
Aminoester derivatives
CHIESI FARM SPA0 citations51
US9453013B2Sep 27, 2016
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CHIESI FARM SPA0 citations51
US10196386B2Feb 5, 2019
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CHIESI FARM SPA0 citations40
US9932338B2Apr 3, 2018
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
CHIESI FARM SPA0 citations40
VANDRIA SA
4 patentsUS11820751B2Nov 21, 2023
Urolithin derivatives and methods of use thereof
VANDRIA SA3 citations69
US12473269B2Nov 18, 2025
Urolithin derivatives and methods of use thereof
VANDRIA SA0 citations58
US12358884B2Jul 15, 2025
Urolithin derivatives and methods of use thereof
VANDRIA SA0 citations58
US12351567B2Jul 8, 2025
Urolithin derivatives and methods of use thereof
VANDRIA SA0 citations58
CHIESI FARMA SPA
3 patentsUS8987299B2Mar 24, 2015
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CHIESI FARMA SPA4 citations72
US8980913B2Mar 17, 2015
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CHIESI FARMA SPA4 citations72
US9371318B2Jun 21, 2016
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CHIESI FARMA SPA1 citations51